journal article·2022-09

Nanocarriers escaping from hyperacidified endo/lysosomes in cancer cells allow tumor-targeted intracellular delivery of antibodies to therapeutically inhibit c-MYC

Pengwen Chen, Wenqian Yang, Taehun Hong, Takuya Miyazaki, Anjaneyulu Dirisala, Kazunori Kataoka, Horacio Cabral

Biomaterials· Volume 288
Publisher page

Abstract

Intracellular protein delivery is a powerful strategy for developing innovative therapeutics. Nanocarriers present great potential to deliver proteins inside cells by promoting cellular uptake and overcoming entrapment and degradation in acidic endo/lysosomal compartments. Thus, because cytosolic access is essential for eliciting the function of proteins, significant efforts have been dedicated to engineering nanocarriers with maximal endosomal escape regardless of the cell type. On the other hand, controlling the ability of nanocarriers to escape from the endo/lysosomal compartments of particular cells may offer the opportunity for enhancing delivery precision. To test this hypothesis, we developed pH-sensitive polymeric nanocarriers with adjustable endosomal escape potency for selectively reaching the cytosol of defined cancer cells with dysregulated endo/lysosomal acidification. By loading antibodies against nuclear pore complex in the nanocarriers, we demonstrated the selective delivery into the cytosol and subsequent nucleus targeting of cancer cells rather than non-cancerous cells both in vitro and in vivo. Systemically injected nanocarriers loading anti-c-MYC antibodies suppressed c-MYC in solid tumors and inhibit tumor growth without side effects, confirming the therapeutic potential of our approach. These results indicated that regulating the ability of nanocarriers to escape from endo/lysosomal compartments in particular cells is a practical approach for gaining delivery specificity.
Source: europepmc · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: RNA Interference and Gene Delivery · Nanoparticle-Based Drug Delivery · Cellular transport and secretion

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (73)

Show source-provided references
1. Hallmarks of cancer: the next generation10.1016/j.cell.2011.02.013 ↗
2. Cell penetrating peptides: the potent multi-cargo intracellular carriers, Expert Opin
3. Intracellular delivery of nanocarriers and targeting to subcellular organelles10.1517/17425247.2015.1086745 ↗
4. Delivery of cancer therapeutics to extracellular and intracellular targets: determinants, barriers, challenges and opportunities10.1016/j.addr.2015.12.002 ↗
5. Improving the endosomal escape of cell-penetrating peptides and their cargos: strategies and challenges
6. Image-based analysis of lipid nanoparticle–mediated siRNA delivery, intracellular trafficking and endosomal escape10.1038/nbt.2612 ↗
7. Efficiency of siRNA delivery by lipid nanoparticles is limited by endocytic recycling10.1038/nbt.2614 ↗
8. Gel–liposome-Mediated Co-delivery of anticancer membrane-associated proteins and small-molecule drugs for enhanced therapeutic efficacy10.1002/adfm.201303222 ↗
9. Systemic nanoparticle delivery of CRISPR-Cas9 ribonucleoproteins for effective tissue specific genome editing10.1038/s41467-020-17029-3 ↗
10. Lipid-based colloidal carriers for peptide and protein delivery – liposomes versus lipid nanoparticles
11. Polymeric micelles loading proteins through concurrent ion complexation and pH-cleavable covalent bonding for in vivo delivery10.1002/mabi.201900161 ↗
12. Protein delivery into cells using inorganic nanoparticle–protein supramolecular assemblies10.1039/C8CS00008E ↗
13. Clinical translation of self-assembled cancer nanomedicines
14. Block copolymer micelles in nanomedicine applications10.1021/acs.chemrev.8b00199 ↗
15. Intracellular delivery of proteins by nanocarriers10.2217/nnm-2016-0393 ↗
16. Rational design of nanocarriers for intracellular protein delivery10.1002/adma.201902791 ↗
17. A display of pH-sensitive fusogenic GALA peptide facilitates endosomal escape from a Bio-nanocapsule via an endocytic uptake pathway10.1186/1477-3155-12-11 ↗
18. An artificial virus-like nano carrier system: enhanced endosomal escape of nanoparticles via synergistic action of pH-sensitive fusogenic peptide derivatives10.1007/s00216-008-2012-1 ↗
19. Carriers break barriers in drug delivery: endocytosis and endosomal escape of gene delivery vectors10.1021/acs.accounts.9b00177 ↗
20. The endosomal escape of nanoparticles: toward more efficient cellular delivery10.1021/acs.bioconjchem.8b00732 ↗
21. DNA-inspired nanomaterials for enhanced endosomal escape10.1073/pnas.2104511118 ↗
22. Effects of hydrophobic core components in amphiphilic PDMAEMA nanoparticles on siRNA delivery10.1016/j.biomaterials.2015.01.026 ↗
23. Design and gene delivery activity of modified polyethylenimines10.1016/S0169-409X(01)00202-2 ↗
24. Cell-Penetrating peptide induces leaky fusion of liposomes containing late endosome-specific anionic lipid10.1016/j.bpj.2010.08.029 ↗
25. Overcoming endosomal barrier by amphotericin B-loaded dual pH-responsive PDMA-b-PDPA micelleplexes for siRNA delivery10.1021/nn203503h ↗
26. An ionizable lipid toolbox for RNA delivery10.1038/s41467-021-27493-0 ↗
27. Fusion of enveloped viruses in endosomes10.1111/tra.12389 ↗
28. Identification of a structural motif crucial for infectivity of hepatitis B viruses10.1073/pnas.0509765103 ↗
29. Sensors and regulators of intracellular pH10.1038/nrm2820 ↗
30. pH-responsive amphiphilic carboxylate polymers: design and potential for endosomal escape
31. A pH-sensitive cationic lipid facilitates the delivery of liposomal siRNA and gene silencing activity in vitro and in vivo10.1016/j.jconrel.2012.09.009 ↗
32. Inspired by nonenveloped viruses escaping from endo-lysosomes: a pH-sensitive polyurethane micelle for effective intracellular trafficking10.1039/C6NR00859C ↗
33. Stimuli-responsive nanocarriers for drug delivery10.1038/nmat3776 ↗
34. A new pH-responsive and glutathione-reactive, endosomal membrane-disruptive polymeric carrier for intracellular delivery of biomolecular drugs10.1016/j.jconrel.2003.06.001 ↗
35. Emerging links between endosomal pH and cancer10.1007/s10555-020-09870-1 ↗
36. Hypoxia-induced mobilization of NHE6 to the plasma membrane triggers endosome hyperacidification and chemoresistance10.1038/ncomms15884 ↗
37. Alkalinization of the lysosomes is correlated with ras transformation of murine and human fibroblasts10.1016/S0021-9258(19)34037-2 ↗
38. Targeted intracellular delivery of antibodies: the state of the art10.3389/fphar.2018.01208 ↗
39. Promises and pitfalls of intracellular delivery of proteins10.1021/bc500320j ↗
40. Drugging the “undruggable” cancer targets10.1038/nrc.2017.36 ↗
41. Drugging the undruggable RAS: mission possible?10.1038/nrd4389 ↗
42. Drugging undruggable molecular cancer targets10.1146/annurev-pharmtox-010715-103440 ↗
43. Drug for an “undruggable” protein10.1038/nature12248 ↗
44. Comparison of transfection efficiency of nonviral gene transfer reagents10.1007/s12033-010-9302-5 ↗
45. Endocytic profiling of cancer cell models reveals critical factors influencing LNP-mediated mRNA delivery and protein expression10.1016/j.ymthe.2019.07.018 ↗
46. Role of endosomes and lysosomes in human disease10.1101/cshperspect.a016931 ↗
47. Defective acidification in human breast tumor cells and implications for chemotherapy10.1084/jem.187.10.1583 ↗
48. Endocytic uptake of SARS-CoV-2: the critical roles of pH, Ca2+, and NAADP10.1093/function/zqaa003 ↗
49. Charge-conversion ternary polyplex with endosome disruption moiety: a technique for efficient and safe gene delivery10.1002/ange.200800963 ↗
50. Polyplexes from poly(aspartamide) bearing 1,2-diaminoethane side chains induce pH-selective, endosomal membrane destabilization with amplified transfection and negligible cytotoxicity10.1021/ja804561g ↗
51. Bundled assembly of helical nanostructures in polymeric micelles loaded with platinum drugs enhancing therapeutic efficiency against pancreatic tumor10.1021/nn500498t ↗
52. Rational design of smart supramolecular assemblies for gene delivery: chemical challenges in the creation of artificial viruses10.1039/C1CS15258K ↗
53. The role of surface charge in cellular uptake and cytotoxicity of medical nanoparticles10.2147/IJN.S36111 ↗
54. Polyethylene glycol-grafted poly-l-lysine as polymeric gene carrier10.1016/S0168-3659(97)00174-0 ↗
55. 569. Novel biodegradable PEG-PLL-g-his multi-block copolymers for non-viral carrier mediated gene therapy10.1016/S1525-0016(16)41011-7 ↗
56. Dual environment-responsive polyplex carriers for enhanced intracellular delivery of plasmid DNA10.1021/bm301095a ↗
57. Intracellular delivery of nanomaterials: how to catch endosomal escape in the act10.1016/j.nantod.2014.04.011 ↗
58. Targeting lysosomal degradation pathways: new strategies and techniques for drug Discovery10.1021/acs.jmedchem.0c01689 ↗
59. Lysosomal degradability of poly(α-amino acids)10.1002/(SICI)1097-4636(19970305)34:3<381::AID-JBM13>3.0.CO;2-J ↗
60. c-Myc target genes involved in cell growth, apoptosis, and metabolism10.1128/MCB.19.1.1 ↗
61. Therapeutic inhibition of Myc in cancer. Structural bases and computer-aided drug Discovery approaches10.3390/ijms20010120 ↗
62. Strategies to inhibit Myc and their clinical applicability10.3389/fcell.2017.00010 ↗
63. Taking the Myc out of cancer: toward therapeutic strategies to directly inhibit c-Myc10.1186/s12943-020-01291-6 ↗
64. Small-molecule MYC inhibitors suppress tumor growth and enhance immunotherapy10.1016/j.ccell.2019.10.001 ↗
66. The EPR effect and beyond: strategies to improve tumor targeting and cancer nanomedicine treatment efficacy10.7150/thno.49577 ↗
67. Protocol for primary mouse hepatocyte isolation10.1016/j.xpro.2020.100086 ↗
68. A cation counterflux supports lysosomal acidification10.1083/jcb.200911083 ↗
69. Relative magnitudes of the rate constants associated with monensin-mediated H+, Na+ and K+ translocations across phospholipid vesicular membranes10.1016/S0005-2736(97)00243-5 ↗
70. Membrane potential and delta pH dependency of reverse electron transport-associated hydrogen peroxide production in brain and heart mitochondria10.1007/s10863-018-9766-8 ↗
71. Aqueous ring-opening polymerization-induced self-assembly (ROPISA) of N-carboxyanhydrides10.1002/anie.201912028 ↗
72. Dynamic PolyConjugates for targeted in vivo delivery of siRNA to hepatocytes10.1073/pnas.0703778104 ↗
73. Tumor acidity-sensitive polymeric vector for active targeted siRNA delivery10.1021/jacs.5b09602 ↗